Paclitaxel With or Without Gemcitabine in Treating Women With Advanced Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Furhan Yunus, MD, FACP
University of Tennessee
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
31 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Comprehensive Cancer Institute of Huntsville
Huntsville, Alabama, United States
- Little Rock Hematology-Oncology Associates
Little Rock, Arkansas, United States
- Pacific Coast Hematology/oncology Medical Group
Fountain Valley, California, United States
- Office of Alex J.P. Makalinao
Los Angeles, California, United States
- Hematology/oncology Group
Santa Rosa, California, United States
- University of Colorado Cancer Center
Denver, Colorado, United States
- Danbury Internal Medicine
Danbury, Connecticut, United States
- Comprehensive Cancer Care Specialists of Boca Raton
Boca Raton, Florida, United States
- Mercy Hospital
Miami, Florida, United States
- Mountain States Tumor Institute
Boise, Idaho, United States
- Memorial Medical Center
Springfield, Illinois, United States
- Carle Cancer Center
Urbana, Illinois, United States
- Indiana Community Cancer Care, Inc.
Indianapolis, Indiana, United States
- Cancer Health Associates
Michigan City, Indiana, United States
- North Mississippi Hematology and Oncology Associates, Ltd.
Tupelo, Mississippi, United States
- St. John'S Mercy Medical Center
St Louis, Missouri, United States
- Apn-Impath Research Corporation
Fort Lee, New Jersey, United States
- Overlook Hospital
Summit, New Jersey, United States
- Hemoncare, P.C.
Brooklyn, New York, United States
- Interlakes Oncology/hematology Pc
Rochester, New York, United States
- N.W. Carolina Oncology & Hematology, P.A.
Hickory, North Carolina, United States
- Oklahoma Oncology Inc.
Tulsa, Oklahoma, United States
- Rittenhouse Hematology/oncology
Philadelphia, Pennsylvania, United States
- South Carolina Oncology Associates
Columbia, South Carolina, United States
- Office of C. Michael Jones
Germantown, Tennessee, United States
- Boston Baskin Cancer Group, University Tennessee Oncology/hematology Group
Memphis, Tennessee, United States
- University of Tennessee, Memphis
Memphis, Tennessee, United States
- Arlington Cancer Center
Arlington, Texas, United States
- Southwest Regional Cancer Center
Austin, Texas, United States
- Intermountain Hematology/oncology Associates, Inc.
Salt Lake City, Utah, United States
- Northern Virginia Oncology Group, P.C.
Fairfax, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2000
- Primary completion
- —
- Completion
- 31 Oct 2005
- Last update posted
- 7 Jun 2012
- Registered enrollment
- —
- Registry id
- NCT00006459
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.